Estrigenix Therapeutics
Therapeutics | Women’s Health and Neurodegenerative Disease
Series Seed | Lead Investor
Milwaukee, Wisconsin
Estrigenix Therapeutics is developing selective estrogen receptor-beta therapeutics for women’s health and neurodegenerative diseases. Its platform is designed to selectively modulate ERβ biology and create differentiated therapeutic opportunities across multiple diseases characterized by significant unmet medical need.